The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0.834. It has been cited 259 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.834
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P30-CA14051
National Institutes of Health
Grant: T32GM007287
NCI NIH HHS
Grant: T32 CA009216
NCI NIH HHS
Grant: P30 CA014051
Entertainment Industry Foundation
Johnson and Johnson
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
American Association for Cancer Research
Broad Institute
Stand up to Cancer
Damon Runyon Cancer Research Foundation
Howard Hughes Medical Institute
Lustgarten Foundation
Howard Hughes Medical Institute
FWCI
14.44
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells
Additional file 1 of Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells